Croda Denmark

Denmark

Croda Denmark was formerly Brenntag Biosector (Biosector), acquired in 2019 and for more than 80 years has been dedicated to safe and effective adjuvants for use in human and veterinary vaccines. No other company can match our expertise in this area.

Our site at Frederikssund includes R&D, engineering, production QA/QC, administration, warehouse and distribution: 

  • World leading adjuvant specialist serving major human and veterinary vaccine producers
  • Industry leading R&D capabilities for a strong pipeline of innovative next generation vaccine adjuvants
  • Running the only aseptic and GMP certified manufacturing site for adjuvants globally

The combination of a passionate team, adjuvant expertise, industry-leading production facilities and a dedicated global sales network committed to understanding customer needs mean we can better serve our pharmaceutical customers through our classic portfolio and our rich development pipeline. We realise the vaccines and blood products of tomorrow require new and innovative adjuvants, so our R&D department is focused on the next generation of adjuvants.

Croda Denmark

Elsenbakken 23
3600 Frederikssund
Denmark

Further reading

2024 full year results

Half year results announcement 2025

29 July 2025: Croda International Plc (“Croda” or the “Group”) the company that uses smart science to create high-performance ingredients and solutions that improve lives, announces its results for...
East asian woman in her 20s with long, straight, bright pink hair.

Croda announces registered name for its innovative non-animal keratin for hair repair.

14 July 2025: Croda International Plc today announce registered name for its innovative non-animal keratin for hair repair.
Croda cuts ribbon at new lipids facility Pennsylvania

Croda opens advanced lipids manufacturing facility in Pennsylvania

18 March 2025: Croda today announces the opening of a pioneering new lipids manufacturing facility in Lamar, Pennsylvania, USA.